Morphine discriminative control Is mediated by the Mu opioid receptor: Assessment of delta opioid substitution and antagonism

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 4, 2000, Pages 851-856

  Stevenson, Glenn W ^a   Cañadas, Fernando ^a   Zhang, Xiaoyan ^b   Rice, Kenner C ^b   Riley, Anthony L ^a  

^a AMERICAN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Conditioned taste aversion; Morphine; Naltrindole; Rat; SNC80

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTRINDOLE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG MECHANISM; FEMALE; HABITUATION; LEARNING; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE AVERSION;

ANIMALS; BENZAMIDES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENERALIZATION, RESPONSE; METHADONE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PIPERAZINES; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0343953032     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00280-X     Document Type: Article

References (51)

1. Akil H., Meng F., Devine D.P., Watson S.J. Molecular and neuroanatomical properties of the endogenous opioid system. Implications for treatment of opiate addiction Semin. Neurosci. 9:1997;70-83.
2. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., McNutt R.W., Rothman R.B., Rice K.C., Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 273:1995;359-366.
3. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., Smith L.E., Bilsky E.J., Davis P., Rice K.C. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80). A highly selective, nonpeptide delta opioid receptor agonist J. Med. Chem. 37:1994;2125-2128.
4. Chen J.C., Smith E.R., Cahill M., Cohen R., Fishman J.B. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52:1993;389-396.
5. Colpaert F.C. Discriminative stimulus properties of narcotic analgesic drugs. Pharmacol. Biochem. Behav. 9:1978;863-887.
6. Gianutsos G., Lal H. Effect of loperamide, haloperidol and methadone in rats trained to discriminate morphine from saline. Psychopharmacologia. 41:1975;267-270.
7. Gianutsos G., Lal H. Selective interaction of drugs with a discriminable stimulus associated with narcotic action. Life Sci. 19:1976;91-98.
8. Gilbert P.E., Martin W.R. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198:1976;66-82.
9. Grabus S.D., Smurthwaite S.T., Riley A.L. Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose. Pharmacol. Biochem. Behav. 63:1999;481-488.
10. Herling S., Valentino R.J., Solomon R.E., Woods J.H. Narcotic discrimination in pigeons. Antagonism by naltrexone Eur. J. Pharmacol. 105:1984;137-142.
11. Hill H.E., Jones B.E., Bell E.C. State dependent control of discrimination by morphine and pentobarbital. Psychopharmacologia. 22:1971;305-313.
12. Jarbe T.U.C. Drug discrimination learning. Cue properties of drugs Greenshaw A.J., Dourish C.T. Experimental psychopharmacology. 1987;433-469 Humana Press, Clifton, NJ.
13. Kautz M.A., Geter B., McBride S.A., Mastropaolo J.P., Riley A.L. Naloxone as a stimulus for drug discrimination learning. Drug Dev. Res. 16:1989;317-326.
14. Locke K.W., Holtzman S.G. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects. J. Pharmacol. Exp. Ther. 238:1986;990-996.
15. Lord J.A., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides. Multiple agonists and receptors Nature. 267:1977;495-499.
16. Magnan J., Paterson S.J., Tavani A., Kosterlitz H.W. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch. Pharmacol. 319:1982;197-205.
17. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
18. Melton P.M., Riley A.L. An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure. Pharmacol. Biochem. Behav. 46:1993;237-242.
19. Melton P.M., Riley A.L. Receptor mediation of the stimulus properties of cholecystokinin. Pharmacol. Biochem. Behav. 48:1994;275-279.
20. Moerschbaecher J.M., Devia C., Brocklehurst C. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats. J. Pharmacol. Exp. Ther. 244:1988;237-246.
21. Negus S.S., Picker M.J., Dykstra L.A. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology (Berlin). 102:1990;465-473.
22. Negus S.S., Gatch M.B., Mello N.K., Zhang X., Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286:1998;362-375.
23. Overton D.A., Leonard W.R., Merkle D.A. Methods for measuring the strength of discriminable drug effects. Neurosci. Biobehav. Rev. 10:1986;251-263.
24. Paterson S.J., Robson L.E., Kosterlitz H.W. Classification of opioid receptors. Br. Med. Bull. 39:1983;31-36.
25. Paule M.G., Wenger G.R. Morphine discrimination in the pigeon using a color tracking procedure. Pharmacol. Biochem. Behav. 24:1986;597-604.
26. Payte J.T. A brief history of methadone in the treatment of opioid dependence. A personal perspective J. Psychoact. Drugs. 23:1991;103-107.
27. Picker M., Heise J.W., Dykstra L.A. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats. Pharmacol. Biochem. Behav. 27:1987;73-80.
28. Platt D.M., Grech D.M., Rowlett J.K., Spealman R.D. Discriminative stimulus effects of morphine in squirrel monkeys. Stimulants, opioids, and stimulant-opioid combinations J. Pharmacol. Exp. Ther. 290:1999;1092-1100.
29. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
30. Reisine T., Pasternak G. Opioid analgesics and antagonists. Gilman A.G., Hardman J.G., Limbard L.E., Molinoff P.M., Ruddon R.W. The pharmacological basis of therapeutics. 1996;521-555 McGraw Hill, New York.
31. Riley A.L., Jeffreys R.D., Pournaghash S., Titley T.L., Kufera A.F. Conditioned taste aversions as a behavioral baseline for drug discrimination learning. Assessment with the dipsogenic compound pentobarbital Drug Dev. Res. 16:1988;229-236.
32. Riley A.L., Kautz M.A., Geter B., Smurthwaite S.T., Pournaghash S., Melton P.M., Ferrari C.M. A demonstration of the graded nature of the generalization function of drug discrimination learning within the conditioned taste aversion procedure. Pharmacol. Biochem. Behav. 2:1991;323-334.
33. Riley A.L. The use of drug discrimination learning in behavioral toxicology. Classification and characterization of toxins Chang L., Slikker A. Handbook of neurotoxicology. Approaches and methodologies:1995;309-321 Academic Press, New York.
34. Riley A.L., Pournaghash S. The effects of chronic morphine on the generalization of buprenorphine stimulus control. An assessment of kappa antagonist activity Pharmacol. Biochem. Behav. 52:1995;779-787.
35. Riley A.L. Drug discrimination learning. Assessment of opioid receptor pharmacology Bouton M.E., Fanselow M.S. Learning, motivation, and cognition. The functional behaviorism of Robert C. Bolles:1997;225-254 American Psychological Association, Bethesda, MD.
36. Riley A.L., Melton P.M. Effects of μ- and δ(-opioid-receptor antagonists on the stimulus properties of cholecystokinin. Pharmacol. Biochem. Behav. 57:1997;57-62.
37. Shannon H.E., Holtzman S.G. Evaluation of the discriminative effects of morphine in the rat. J. Pharmacol. Exp. Ther. 198:1976;54-65.
38. Shannon H.E., Holtzman S.G. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Psychopharmacology (Berlin). 50:1976;119-124.
39. Shannon H.E., Holtzman S.G. Further evaluation of the discriminative effects of morphine in the rat. J. Pharmacol. Exp. Ther. 201:1977;55-56.
40. Shannon H.E., Holtzman S.G. Discriminative effects of morphine administered intracerebrally in the rat. Life Sci. 21:1977;585-594.
41. Smurthwaite S.T., Kautz M.A., Geter B., Riley A.L. Naloxone as a stimulus in drug discrimination learning. Generalization to other opiate antagonists Pharmacol. Biochem. Behav. 41:1992;43-47.
42. Smurthwaite S.T., Riley A.L. Diprenorphine as a stimulus in drug discrimination learning. Pharmacol. Biochem. Behav. 43:1992;1-8.
43. Smurthwaite S.T., Riley A.L. Nalorphine as a stimulus in drug discrimination learning. Assessment of the role of μ- and κ-receptor subtypes Pharmacol. Biochem. Behav. 48:1994;635-642.
44. Sobel B.-F.X., Wetherington C.L., Riley A.L. The contribution of within session averaging of drug- and vehicle-appropriate responding to the graded dose-response function in drug discrimination learning. Behav. Pharmacol. 6:1995;348-358.
45. Stevenson G.W., Pournaghash S., Riley A.L. Antagonism of drug discrimination learning within the conditioned taste aversion procedure. Pharmacol. Biochem. Behav. 41:1992;245-249.
46. Suzuki T., Yoshiike M., Mizoguchi H., Kamei J., Misawa M., Nagase H. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmacol. 66:1994;131-137.
47. Teal J.J., Holtzman S.G. Stimulus effects of morphine in the monkey. quantitative analysis of antagonism Pharmacol. Biochem. Behav. 12:1980;587-593.
48. Ukai M., Holtzman S.G. Morphine-like discriminative stimulus effects of opioid peptides. Possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13) Psychopharmacology (Berlin). 94:1988;32-37.
49. Winter J.C. The stimulus properties of morphine and ethanol. Psychopharmacologia. 44:1975;209-214.
50. Woods J.H., Bertalmio A.J., Young A.M., Essman W.D., Winger G. Receptor mechanisms of opioid drug discrimination. Colpaert F.C., Balster R.L. Psychopharmacology series 4; Transduction mechanisms of drug stimuli. 1988;Springer-Verlag, Berlin.
51. Young A.M., Woods J.H., Herling S., Hein D.W. Comparison of the reinforcing and discriminative stimulus properties of opioids and opioid peptides. Smith J.E., Lane J.D. The neurobiology of opiate reward processes. 1983;Elsevier Biomedical Press, Amsterdam.